Oscar Health (NYSE:OSCR) Stock Rating Lowered by Wall Street Zen

Oscar Health (NYSE:OSCR) was downgraded by equities research analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Saturday.

Several other equities analysts have also recently weighed in on the company. Robert W. Baird lifted their price target on Oscar Health from $15.00 to $19.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. Jefferies Financial Group upgraded Oscar Health from an “underperform” rating to a “hold” rating and lifted their price target for the company from $10.00 to $16.00 in a research report on Monday, April 20th. Zacks Research upgraded Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, May 7th. Weiss Ratings reissued a “sell (d)” rating on shares of Oscar Health in a research note on Tuesday, April 21st. Finally, Wolfe Research assumed coverage on Oscar Health in a research note on Tuesday, May 5th. They set a “peer perform” rating for the company. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Oscar Health presently has an average rating of “Hold” and a consensus price target of $20.22.

Oscar Health Price Performance

Shares of NYSE OSCR opened at $24.59 on Friday. The stock has a market cap of $7.41 billion, a PE ratio of -41.68, a price-to-earnings-growth ratio of 1.65 and a beta of 2.37. Oscar Health has a fifty-two week low of $10.69 and a fifty-two week high of $25.58. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.11 and a current ratio of 1.11. The stock has a fifty day moving average of $18.39 and a 200-day moving average of $16.06.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.96. The company had revenue of $4.65 billion during the quarter, compared to analysts’ expectations of $4.90 billion. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The firm’s quarterly revenue was up 52.6% compared to the same quarter last year. During the same period in the previous year, the business earned $0.92 earnings per share. Equities research analysts anticipate that Oscar Health will post 0.47 earnings per share for the current year.

Insider Activity at Oscar Health

In related news, CFO Richard Scott Blackley sold 31,683 shares of Oscar Health stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total transaction of $695,125.02. Following the completion of the sale, the chief financial officer owned 1,074,977 shares of the company’s stock, valued at approximately $23,584,995.38. This trade represents a 2.86% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Mario Schlosser sold 34,120 shares of Oscar Health stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total value of $748,592.80. Following the sale, the director directly owned 480,866 shares of the company’s stock, valued at $10,550,200.04. This represents a 6.63% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 189,660 shares of company stock valued at $4,283,140 in the last ninety days. 24.39% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Oscar Health

Large investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its stake in Oscar Health by 2.7% during the fourth quarter. Vanguard Group Inc. now owns 20,701,250 shares of the company’s stock worth $297,477,000 after purchasing an additional 540,851 shares during the last quarter. State of Michigan Retirement System bought a new stake in Oscar Health during the third quarter worth about $27,448,000. Universal Beteiligungs und Servicegesellschaft mbH lifted its stake in Oscar Health by 1,097.8% during the fourth quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 237,882 shares of the company’s stock worth $3,418,000 after purchasing an additional 218,022 shares during the last quarter. Farallon Capital Management LLC lifted its stake in Oscar Health by 146.5% during the third quarter. Farallon Capital Management LLC now owns 3,639,000 shares of the company’s stock worth $68,886,000 after purchasing an additional 2,163,000 shares during the last quarter. Finally, Fred Alger Management LLC lifted its stake in Oscar Health by 225.6% during the third quarter. Fred Alger Management LLC now owns 1,212,383 shares of the company’s stock worth $22,950,000 after purchasing an additional 840,038 shares during the last quarter. Institutional investors own 75.70% of the company’s stock.

Trending Headlines about Oscar Health

Here are the key news stories impacting Oscar Health this week:

• Positive Sentiment: Wells Fargo upgraded Oscar Health from “strong sell” to “hold”, easing bearish sentiment even though its $20 target remains below the current share price. Zacks.com
• Positive Sentiment: Oscar Health’s recent earnings showed a major EPS beat, which supports the stock’s fundamental story despite revenue coming in below estimates.
• Neutral Sentiment: A company co-founder shifting into an advisory leadership role looks like an internal reorganization rather than a disruptive change. Oscar Health Co-Founder Shifts to Advisory Leadership Role
• Neutral Sentiment: Multiple insiders, including CFO Richard Scott Blackley and CAO Victoria Baltrus, sold shares under pre-planned 10b5-1 programs to cover tax obligations on vested equity awards, which is less concerning than discretionary selling.
• Negative Sentiment: Director Mario Schlosser sold 34,120 shares, the largest insider sale in the latest batch, which may pressure sentiment even though it was pre-arranged.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.